Cyanotech (OTCMKTS:CYAN – Get Free Report) and Ascend Wellness (OTCMKTS:AAWH – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership and dividends.
Profitability
This table compares Cyanotech and Ascend Wellness’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cyanotech | -7.03% | -20.62% | -7.52% |
| Ascend Wellness | -26.24% | -1,099.51% | -12.44% |
Earnings & Valuation
This table compares Cyanotech and Ascend Wellness”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cyanotech | $24.22 million | 0.16 | -$3.20 million | ($0.25) | -2.08 |
| Ascend Wellness | $500.58 million | 0.22 | -$118.19 million | ($0.64) | -0.84 |
Cyanotech has higher earnings, but lower revenue than Ascend Wellness. Cyanotech is trading at a lower price-to-earnings ratio than Ascend Wellness, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Cyanotech has a beta of 0.17, indicating that its stock price is 83% less volatile than the S&P 500. Comparatively, Ascend Wellness has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500.
Institutional and Insider Ownership
24.4% of Cyanotech shares are owned by institutional investors. Comparatively, 17.3% of Ascend Wellness shares are owned by institutional investors. 34.4% of Cyanotech shares are owned by insiders. Comparatively, 21.6% of Ascend Wellness shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Cyanotech and Ascend Wellness, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cyanotech | 0 | 0 | 0 | 0 | 0.00 |
| Ascend Wellness | 0 | 1 | 0 | 0 | 2.00 |
Summary
Cyanotech beats Ascend Wellness on 7 of the 12 factors compared between the two stocks.
About Cyanotech
Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.
About Ascend Wellness
Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in New York, New York.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.
